Compare CRI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRI | RAPP |
|---|---|---|
| Founded | 1865 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2002 | 2024 |
| Metric | CRI | RAPP |
|---|---|---|
| Price | $34.86 | $36.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $34.00 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 848.4K | 240.6K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | N/A | ★ 24.34 |
| EPS | ★ 2.53 | N/A |
| Revenue | ★ $2,898,426,000.00 | N/A |
| Revenue This Year | $4.50 | N/A |
| Revenue Next Year | $1.02 | N/A |
| P/E Ratio | $13.70 | ★ N/A |
| Revenue Growth | ★ 1.91 | N/A |
| 52 Week Low | $23.38 | $7.73 |
| 52 Week High | $44.44 | $42.27 |
| Indicator | CRI | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 72.76 |
| Support Level | $31.90 | $25.48 |
| Resistance Level | $39.05 | $42.27 |
| Average True Range (ATR) | 1.43 | 1.97 |
| MACD | 0.06 | 0.58 |
| Stochastic Oscillator | 26.75 | 96.56 |
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.